DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases

Abstract

The KDM5/JARID1 family of Fe(II)- and α-ketoglutarate-dependent demethylases remove methyl groups from tri- and dimethylated lysine 4 of histone H3. Accumulating evidence from primary tumors and model systems supports a role for KDM5A (JARID1A/RBP2) and KDM5B (JARID1B/PLU1) as oncogenic drivers. The KDM5 family is unique among the Jumonji domain-containing histone demethylases in that there is an atypical insertion of a DNA-binding ARID domain and a histone-binding PHD domain into the Jumonji domain, which separates the catalytic domain into two fragments (JmjN and JmjC). Here we demonstrate that internal deletion of the ARID and PHD1 domains has a negligible effect on in vitro enzymatic kinetics of the KDM5 family of enzymes. We present a crystal structure of the linked JmjN-JmjC domain from KDM5A, which reveals that the linked domain fully reconstitutes the cofactor (metal ion and α-ketoglutarate) binding characteristics of other structurally characterized Jumonji domain demethylases. Docking studies with GSK-J1, a selective inhibitor of the KDM6/KDM5 subfamilies, identify critical residues for binding of the inhibitor to the reconstituted KDM5 Jumonji domain. Further, we found that GSK-J1 inhibited the demethylase activity of KDM5C with 8.5-fold increased potency compared with that of KDM5B at 1 mm α-ketoglutarate. In contrast, JIB-04 (a pan-inhibitor ofmore » the Jumonji demethylase superfamily) had the opposite effect and was ~8-fold more potent against KDM5B than against KDM5C. Interestingly, the relative selectivity of JIB-04 toward KDM5B over KDM5C in vitro translates to a ~10–50-fold greater growth-inhibitory activity against breast cancer cell lines. Here, these data define the minimal requirements for enzymatic activity of the KDM5 family to be the linked JmjN-JmjC domain coupled with the immediate C-terminal helical zinc-binding domain and provide structural characterization of the linked JmjN-JmjC domain for the KDM5 family, which should prove useful in the design of KDM5 demethylase inhibitors with improved potency and selectivity.« less

Authors:
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1]
  1. Emory Univ., Atlanta, GA (United States)
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
NCI; National Institutes of Health (NIH)
OSTI Identifier:
1237765
Grant/Contract Number:  
HHSN261200800001E; GM114306-01; P30-CA138292
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Biological Chemistry
Additional Journal Information:
Journal Volume: 291; Journal Issue: 6; Journal ID: ISSN 0021-9258
Publisher:
American Society for Biochemistry and Molecular Biology
Country of Publication:
United States
Language:
ENGLISH
Subject:
59 BASIC BIOLOGICAL SCIENCES; 37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY; dioxygenase; histone demethylase; histone modification; metal ion-protein interaction; molecular modeling

Citation Formats

Horton, John R., Engstrom, Amanda, Zoeller, Elizabeth L., Liu, Xu, Shanks, John R., Zhang, Xing, Johns, Margaret A., Vertino, Paula M., Fu, Haian, and Cheng, Xiaodong. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases. United States: N. p., 2015. Web. doi:10.1074/jbc.M115.698449.
Horton, John R., Engstrom, Amanda, Zoeller, Elizabeth L., Liu, Xu, Shanks, John R., Zhang, Xing, Johns, Margaret A., Vertino, Paula M., Fu, Haian, & Cheng, Xiaodong. Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases. United States. https://doi.org/10.1074/jbc.M115.698449
Horton, John R., Engstrom, Amanda, Zoeller, Elizabeth L., Liu, Xu, Shanks, John R., Zhang, Xing, Johns, Margaret A., Vertino, Paula M., Fu, Haian, and Cheng, Xiaodong. Tue . "Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases". United States. https://doi.org/10.1074/jbc.M115.698449. https://www.osti.gov/servlets/purl/1237765.
@article{osti_1237765,
title = {Characterization of a Linked Jumonji Domain of the KDM5/JARID1 Family of Histone H3 Lysine 4 Demethylases},
author = {Horton, John R. and Engstrom, Amanda and Zoeller, Elizabeth L. and Liu, Xu and Shanks, John R. and Zhang, Xing and Johns, Margaret A. and Vertino, Paula M. and Fu, Haian and Cheng, Xiaodong},
abstractNote = {The KDM5/JARID1 family of Fe(II)- and α-ketoglutarate-dependent demethylases remove methyl groups from tri- and dimethylated lysine 4 of histone H3. Accumulating evidence from primary tumors and model systems supports a role for KDM5A (JARID1A/RBP2) and KDM5B (JARID1B/PLU1) as oncogenic drivers. The KDM5 family is unique among the Jumonji domain-containing histone demethylases in that there is an atypical insertion of a DNA-binding ARID domain and a histone-binding PHD domain into the Jumonji domain, which separates the catalytic domain into two fragments (JmjN and JmjC). Here we demonstrate that internal deletion of the ARID and PHD1 domains has a negligible effect on in vitro enzymatic kinetics of the KDM5 family of enzymes. We present a crystal structure of the linked JmjN-JmjC domain from KDM5A, which reveals that the linked domain fully reconstitutes the cofactor (metal ion and α-ketoglutarate) binding characteristics of other structurally characterized Jumonji domain demethylases. Docking studies with GSK-J1, a selective inhibitor of the KDM6/KDM5 subfamilies, identify critical residues for binding of the inhibitor to the reconstituted KDM5 Jumonji domain. Further, we found that GSK-J1 inhibited the demethylase activity of KDM5C with 8.5-fold increased potency compared with that of KDM5B at 1 mm α-ketoglutarate. In contrast, JIB-04 (a pan-inhibitor of the Jumonji demethylase superfamily) had the opposite effect and was ~8-fold more potent against KDM5B than against KDM5C. Interestingly, the relative selectivity of JIB-04 toward KDM5B over KDM5C in vitro translates to a ~10–50-fold greater growth-inhibitory activity against breast cancer cell lines. Here, these data define the minimal requirements for enzymatic activity of the KDM5 family to be the linked JmjN-JmjC domain coupled with the immediate C-terminal helical zinc-binding domain and provide structural characterization of the linked JmjN-JmjC domain for the KDM5 family, which should prove useful in the design of KDM5 demethylase inhibitors with improved potency and selectivity.},
doi = {10.1074/jbc.M115.698449},
journal = {Journal of Biological Chemistry},
number = 6,
volume = 291,
place = {United States},
year = {Tue Dec 08 00:00:00 EST 2015},
month = {Tue Dec 08 00:00:00 EST 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 83 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug
journal, January 2007

  • Marks, Paul A.; Breslow, Ronald
  • Nature Biotechnology, Vol. 25, Issue 1
  • DOI: 10.1038/nbt1272

Linking Crystallographic Model and Data Quality
journal, May 2012


Delivery of 5-Aza-2'-Deoxycytidine to Cells Using Oligodeoxynucleotides
journal, July 2007


Balancing of Histone H3K4 Methylation States by the Kdm5c/SMCX Histone Demethylase Modulates Promoter and Enhancer Function
journal, April 2013


KDM1 histone lysine demethylases as targets for treatments of oncological and neurodegenerative disease
journal, June 2015

  • Maes, Tamara; Mascaró, Cristina; Ortega, Alberto
  • Epigenomics, Vol. 7, Issue 4
  • DOI: 10.2217/epi.15.9

Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
journal, July 2011


Inhibition of demethylases by GSK-J1/J4
journal, October 2014

  • Heinemann, Bo; Nielsen, Jesper Morten; Hudlebusch, Heidi Rye
  • Nature, Vol. 514, Issue 7520
  • DOI: 10.1038/nature13688

Enzymatic and structural insights for substrate specificity of a family of jumonji histone lysine demethylases
journal, December 2009

  • Horton, John R.; Upadhyay, Anup K.; Qi, Hank H.
  • Nature Structural & Molecular Biology, Vol. 17, Issue 1
  • DOI: 10.1038/nsmb.1753

Assessing and maximizing data quality in macromolecular crystallography
journal, October 2015


Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1
journal, December 2004


Catalytic Mechanisms of Fe(II)- and 2-Oxoglutarate-dependent Oxygenases
journal, July 2015

  • Martinez, Salette; Hausinger, Robert P.
  • Journal of Biological Chemistry, Vol. 290, Issue 34
  • DOI: 10.1074/jbc.R115.648691

A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth
journal, June 2013

  • Wang, Lei; Chang, Jianjun; Varghese, Diana
  • Nature Communications, Vol. 4, Issue 1
  • DOI: 10.1038/ncomms3035

The landscape of histone modifications across 1% of the human genome in five human cell lines
journal, June 2007

  • Koch, C. M.; Andrews, R. M.; Flicek, P.
  • Genome Research, Vol. 17, Issue 6
  • DOI: 10.1101/gr.5704207

Backbone and sidechain 1H, 13C and 15N resonance assignments of the Bright/ARID domain from the human JARID1C (SMCX) protein
journal, December 2007

  • Koehler, Christian; Bishop, Shurene; Dowler, Elizabeth F.
  • Biomolecular NMR Assignments, Vol. 2, Issue 1
  • DOI: 10.1007/s12104-007-9071-7

The Phyre2 web portal for protein modeling, prediction and analysis
journal, May 2015

  • Kelley, Lawrence A.; Mezulis, Stefans; Yates, Christopher M.
  • Nature Protocols, Vol. 10, Issue 6
  • DOI: 10.1038/nprot.2015.053

Lysine Demethylase KDM4A Associates with Translation Machinery and Regulates Protein Synthesis
journal, January 2015


Functional Analysis of the Transcription Repressor PLU-1/JARID1B
journal, August 2007

  • Scibetta, A. G.; Santangelo, S.; Coleman, J.
  • Molecular and Cellular Biology, Vol. 27, Issue 20
  • DOI: 10.1128/MCB.00274-07

PHENIX : building new software for automated crystallographic structure determination
journal, October 2002

  • Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li-Wei
  • Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11
  • DOI: 10.1107/S0907444902016657

Loss of the retinoblastoma binding protein 2 (RBP2) histone demethylase suppresses tumorigenesis in mice lacking Rb1 or Men1
journal, July 2011

  • Lin, W.; Cao, J.; Liu, J.
  • Proceedings of the National Academy of Sciences, Vol. 108, Issue 33
  • DOI: 10.1073/pnas.1110104108

A Temporarily Distinct Subpopulation of Slow-Cycling Melanoma Cells Is Required for Continuous Tumor Growth
journal, May 2010


Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome
journal, February 2007

  • Heintzman, Nathaniel D.; Stuart, Rhona K.; Hon, Gary
  • Nature Genetics, Vol. 39, Issue 3
  • DOI: 10.1038/ng1966

PLU-1 Is an H3K4 Demethylase Involved in Transcriptional Repression and Breast Cancer Cell Proliferation
journal, March 2007


The ARID domain of the H3K4 demethylase RBP2 binds to a DNA CCGCCC motif
journal, February 2008

  • Tu, Shengjiang; Teng, Yu-Ching; Yuan, Chunhua
  • Nature Structural & Molecular Biology, Vol. 15, Issue 4
  • DOI: 10.1038/nsmb.1400

JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer
journal, November 2007

  • Xiang, Y.; Zhu, Z.; Han, G.
  • Proceedings of the National Academy of Sciences, Vol. 104, Issue 49
  • DOI: 10.1073/pnas.0700735104

An Analog of BIX-01294 Selectively Inhibits a Family of Histone H3 Lysine 9 Jumonji Demethylases
journal, February 2012

  • Upadhyay, Anup K.; Rotili, Dante; Han, Ji Woong
  • Journal of Molecular Biology, Vol. 416, Issue 3
  • DOI: 10.1016/j.jmb.2011.12.036

Prolonged and tunable residence time using reversible covalent kinase inhibitors
journal, May 2015

  • Bradshaw, J. Michael; McFarland, Jesse M.; Paavilainen, Ville O.
  • Nature Chemical Biology, Vol. 11, Issue 7
  • DOI: 10.1038/nchembio.1817

JARID1B Is a Luminal Lineage-Driving Oncogene in Breast Cancer
journal, June 2014


Targeting Epigenetic Readers in Cancer
journal, August 2012

  • Dawson, Mark A.; Kouzarides, Tony; Huntly, Brian J. P.
  • New England Journal of Medicine, Vol. 367, Issue 7
  • DOI: 10.1056/NEJMra1112635

Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger
journal, June 2009

  • Wang, Gang G.; Song, Jikui; Wang, Zhanxin
  • Nature, Vol. 459, Issue 7248
  • DOI: 10.1038/nature08036

Romidepsin: a novel histone deacetylase inhibitor for cancer
journal, June 2011


Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
journal, January 2010

  • Dalgliesh, Gillian L.; Furge, Kyle; Greenman, Chris
  • Nature, Vol. 463, Issue 7279
  • DOI: 10.1038/nature08672

A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
journal, April 2010


Kinetic studies of Escherichia coli AlkB using a new fluorescence-based assay for DNA demethylation
journal, November 2007

  • Roy, Todd W.; Bhagwat, A. S.
  • Nucleic Acids Research, Vol. 35, Issue 21
  • DOI: 10.1093/nar/gkm1031

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
journal, October 2012

  • McCabe, Michael T.; Ott, Heidi M.; Ganji, Gopinath
  • Nature, Vol. 492, Issue 7427
  • DOI: 10.1038/nature11606

Epigenetic therapy of cancer: past, present and future
journal, January 2006

  • Yoo, Christine B.; Jones, Peter A.
  • Nature Reviews Drug Discovery, Vol. 5, Issue 1
  • DOI: 10.1038/nrd1930

EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity
journal, March 2015


The H3K4-Methyl Epigenome Regulates Leukemia Stem Cell Oncogenic Potential
journal, August 2015


A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLC
journal, July 2015

  • Mohammad, Helai P.; Smitheman, Kimberly N.; Kamat, Chandrashekhar D.
  • Cancer Cell, Vol. 28, Issue 1
  • DOI: 10.1016/j.ccell.2015.06.002

Structural basis for histone H3 Lys 27 demethylation by UTX/KDM6A
journal, October 2011


Potent inhibition of DOT1L as treatment of MLL-fusion leukemia
journal, August 2013


Cloning of cDNAs for cellular proteins that bind to the retinoblastoma gene product
journal, July 1991

  • Defeo-Jones, Deborah; Huang, Pearl S.; Jones, Raymond E.
  • Nature, Vol. 352, Issue 6332
  • DOI: 10.1038/352251a0

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Structural definitions of Jumonji family demethylase selectivity
journal, June 2015


Cancer Epigenetics: From Mechanism to Therapy
journal, July 2012


Features and development of Coot
journal, March 2010

  • Emsley, P.; Lohkamp, B.; Scott, W. G.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4
  • DOI: 10.1107/S0907444910007493

The Epigenomics of Cancer
journal, February 2007


Targeting H3K4 trimethylation in Huntington disease
journal, July 2013

  • Vashishtha, M.; Ng, C. W.; Yildirim, F.
  • Proceedings of the National Academy of Sciences, Vol. 110, Issue 32
  • DOI: 10.1073/pnas.1311323110

Structural Basis of a Histone H3 Lysine 4 Demethylase Required for Stem Elongation in Rice
journal, January 2013


A Novel Gene ( PLU-1 ) Containing Highly Conserved Putative DNA/Chromatin Binding Motifs Is Specifically Up-regulated in Breast Cancer
journal, May 1999

  • Lu, Pei Juan; Sundquist, Kristina; Baeckstrom, Dan
  • Journal of Biological Chemistry, Vol. 274, Issue 22
  • DOI: 10.1074/jbc.274.22.15633

Genetic Events That Shape the Cancer Epigenome
journal, June 2012


PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity
journal, June 2007

  • Ng, Stanley S.; Kavanagh, Kathryn L.; McDonough, Michael A.
  • Nature, Vol. 448, Issue 7149
  • DOI: 10.1038/nature05971

Chemical phylogenetics of histone deacetylases
journal, February 2010

  • Bradner, James E.; West, Nathan; Grachan, Melissa L.
  • Nature Chemical Biology, Vol. 6, Issue 3
  • DOI: 10.1038/nchembio.313

Binding of pRB to the PHD Protein RBP2 Promotes Cellular Differentiation
journal, June 2005


Structure of a Naegleria Tet-like dioxygenase in complex with 5-methylcytosine DNA
journal, December 2013

  • Hashimoto, Hideharu; Pais, June E.; Zhang, Xing
  • Nature, Vol. 506, Issue 7488
  • DOI: 10.1038/nature12905

The X-Linked Mental Retardation Gene SMCX/JARID1C Defines a Family of Histone H3 Lysine 4 Demethylases
journal, March 2007


The Retinoblastoma Binding Protein RBP2 Is an H3K4 Demethylase
journal, March 2007


The ankyrin repeats of G9a and GLP histone methyltransferases are mono- and dimethyllysine binding modules
journal, February 2008

  • Collins, Robert E.; Northrop, Jeffrey P.; Horton, John R.
  • Nature Structural & Molecular Biology, Vol. 15, Issue 3
  • DOI: 10.1038/nsmb.1384

Histone Demethylase RBP2 Is Critical for Breast Cancer Progression and Metastasis
journal, March 2014


A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response
journal, July 2012

  • Kruidenier, Laurens; Chung, Chun-wa; Cheng, Zhongjun
  • Nature, Vol. 488, Issue 7411
  • DOI: 10.1038/nature11262

KDM5B focuses H3K4 methylation near promoters and enhancers during embryonic stem cell self-renewal and differentiation
journal, January 2014


Multiparametric scaling of diffraction intensities
journal, April 2003

  • Otwinowski, Zbyszek; Borek, Dominika; Majewski, Wladyslaw
  • Acta Crystallographica Section A Foundations of Crystallography, Vol. 59, Issue 3
  • DOI: 10.1107/S0108767303005488

Epigenetic protein families: a new frontier for drug discovery
journal, April 2012

  • Arrowsmith, Cheryl H.; Bountra, Chas; Fish, Paul V.
  • Nature Reviews Drug Discovery, Vol. 11, Issue 5
  • DOI: 10.1038/nrd3674

Histone demethylase KDM5A is regulated by its reader domain through a positive-feedback mechanism
journal, February 2015

  • Torres, Idelisse Ortiz; Kuchenbecker, Kristopher M.; Nnadi, Chimno I.
  • Nature Communications, Vol. 6, Issue 1
  • DOI: 10.1038/ncomms7204

Recognition of unmethylated histone H3 lysine 4 links BHC80 to LSD1-mediated gene repression
journal, August 2007

  • Lan, Fei; Collins, Robert E.; De Cegli, Rossella
  • Nature, Vol. 448, Issue 7154
  • DOI: 10.1038/nature06034

The KDM5 family of histone demethylases as targets in oncology drug discovery
journal, June 2014

  • Rasmussen, Peter Birk; Staller, Peter
  • Epigenomics, Vol. 6, Issue 3
  • DOI: 10.2217/epi.14.14

JmjC Lysine Demethylases
book, May 2015


PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome
journal, December 2019


Cavin1 intrinsically disordered domains are essential for fuzzy electrostatic interactions and caveola formation
journal, February 2021


PHENIX: a comprehensive Python-based system for macromolecular structure solution.
text, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Apollo - University of Cambridge Repository
  • DOI: 10.17863/cam.45787

Works referencing / citing this record:

KDM5 demethylases and their role in cancer cell chemoresistance: KDM5 demethylases
journal, November 2018

  • Plch, Johana; Hrabeta, Jan; Eckschlager, Tomas
  • International Journal of Cancer, Vol. 144, Issue 2
  • DOI: 10.1002/ijc.31881

Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals
book, August 2019

  • Shukla, Samriddhi; Penta, Dhanamjai; Mondal, Priya
  • Breast Cancer Metastasis and Drug Resistance: Challenges and Progress, p. 293-310
  • DOI: 10.1007/978-3-030-20301-6_16

Extended Recognition of the Histone H3 Tail by Histone Demethylase KDM5A
journal, January 2020

  • Petronikolou, Nektaria; Longbotham, James E.; Fujimori, Danica Galonić
  • Biochemistry, Vol. 59, Issue 5
  • DOI: 10.1021/acs.biochem.9b01036

Structural analysis of human KDM5B guides histone demethylase inhibitor development
journal, May 2016

  • Johansson, Catrine; Velupillai, Srikannathasan; Tumber, Anthony
  • Nature Chemical Biology, Vol. 12, Issue 7
  • DOI: 10.1038/nchembio.2087

Histone H3 binding to the PHD1 domain of histone demethylase KDM5A enables active site remodeling
journal, January 2019

  • Longbotham, James E.; Chio, Cynthia M.; Dharmarajan, Venkatasubramanian
  • Nature Communications, Vol. 10, Issue 1
  • DOI: 10.1038/s41467-018-07829-z

The transition structure of chromatin fibers at the nanoscale probed by cryogenic electron tomography
journal, January 2019

  • Zhou, Zhongwu; Li, Kunpeng; Yan, Rui
  • Nanoscale, Vol. 11, Issue 29
  • DOI: 10.1039/c9nr02042j

JARID1/KDM5 demethylases as cancer targets?
journal, November 2016


A CRISPR/Cas9 screen identifies the histone demethylase MINA53 as a novel HIV-1 latency-promoting gene (LPG)
journal, June 2019

  • Huang, Huachao; Kong, Weili; Jean, Maxime
  • Nucleic Acids Research, Vol. 47, Issue 14
  • DOI: 10.1093/nar/gkz493

Histone Lysine Demethylase Inhibitors
journal, October 2016

  • Jambhekar, Ashwini; Anastas, Jamie N.; Shi, Yang
  • Cold Spring Harbor Perspectives in Medicine, Vol. 7, Issue 1
  • DOI: 10.1101/cshperspect.a026484

The H3K4 demethylase Jar1 orchestrates ROS production and expression of pathogenesis‐related genes to facilitate Botrytis cinerea virulence
journal, October 2019

  • Hou, Jie; Feng, Hui‐Qiang; Chang, Hao‐Wu
  • New Phytologist, Vol. 225, Issue 2
  • DOI: 10.1111/nph.16200

Xue-fu-Zhu-Yu decoction protects rats against retinal ischemia by downregulation of HIF-1α and VEGF via inhibition of RBP2 and PKM2
journal, July 2017

  • Tan, Shu-Qiu; Geng, Xue; Liu, Jorn-Hon
  • BMC Complementary and Alternative Medicine, Vol. 17, Issue 1
  • DOI: 10.1186/s12906-017-1857-2

Assessing histone demethylase inhibitors in cells: lessons learned
journal, March 2017

  • Hatch, Stephanie B.; Yapp, Clarence; Montenegro, Raquel C.
  • Epigenetics & Chromatin, Vol. 10, Issue 1
  • DOI: 10.1186/s13072-017-0116-6

Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor
journal, August 2018

  • Kuo, Kuang-Tai; Huang, Wen-Chien; Bamodu, Oluwaseun Adebayo
  • Clinical Epigenetics, Vol. 10, Issue 1
  • DOI: 10.1186/s13148-018-0533-9

Genetic heterogeneity within collective invasion packs drives leader and follower cell phenotypes
journal, September 2019

  • Zoeller, Elizabeth L.; Pedro, Brian; Konen, Jessica
  • Journal of Cell Science, Vol. 132, Issue 19
  • DOI: 10.1242/jcs.231514

KDM5 histone demethylases repress immune response via suppression of STING
journal, August 2018